A dramatic increase in the thyroid cancer rate across the last 30 years has researchers asking whether the disease’s incidence is truly on the rise, or if improved detection methods are behind the trend.
Seeking the patient voice early in the cessation process is critical to success.
Hepatitis C virus infection is a common cause of liver disease and of liver cancer in the United States. Through a new study that explores one aspect of how the virus hijacks host cell machinery to replicate itself, UNC Lineberger Comprehensive Cancer Center researchers have gained insight into the workings of a potential drug target for hepatitis C.
The UNC Lineberger Comprehensive Cancer Support Program (CCSP) is now recruiting patients for a new online survey-based research study on the experiences of parents living with advanced cancer.
The ninth annual UNC Multidisciplinary Melanoma Conference brought more than 120 health care professionals from across the state on Thursday, February 12 to learn about the detection and treatment of melanoma.
The latest installment in UNC Health Care's Real Medicine video series features Ashley Burnette, 11-year-old cancer survivor and Patient Ambassador at the North Carolina Children's Hospital.
With new funding, a UNC startup is poised to halt the most devastating effects of chemotherapy.
To give back to an institution that he credits with saving his mother’s life, America’s top-ranked men’s singles tennis player John Isner returned to his hometown of Greensboro on Saturday, February 7th for his annual tennis exhibition event.
To identify important medical questions that haven’t been fully answered by researchers yet, doctor and researcher Angela Smith is turning to patients for guidance.
Most 12 year olds collect Pokemon or baseball cards. But, for 7th grader Gray Garber, it’s hats. And not just any hats. Hats that are fun, happy and perfectly soft on the inside – soft enough for the delicate heads of pediatric cancer patients at the N.C. Cancer Hospital.
One of nation’s top universities yields more than 150 startup companies to date, including G1 Therapeutics, creating jobs and advancing innovation and entrepreneurship.
Device that drives drugs into solid tumors that are poorly vascularized opens the possibility of life-saving surgeries in cancer patients.
After comparing the survival outcomes of older and younger people with head and neck cancer, UNC Lineberger researchers have found that age alone shouldn’t dictate a patient’s treatment. The findings were published January 12 online in the journal The Oncologist.
UNC Board of Trustees chair and cancer survivor Lowry Caudill headlines 28th Annual Lineberger Club event
Nearly 300 UNC Lineberger Comprehensive Cancer Center supporters gathered at the Carolina Inn to hear the remarks of distinguished UNC alumnus Lowry Caudill, PhD, on January 24, 2015 during the 28th Annual Lineberger Club Lunch and Basketball Game.
A UNC Lineberger researcher has pointed to a need for more data on whether new technology designed to better detect men at higher-risk for prostate cancer will also mean improvements in survival rates and symptoms.
When a young woman receives a cancer diagnosis, her obvious first thought is “I want to survive this.” When that cancer diagnosis has an impact on her ability to have children, she has a second thought.
A study co-led by a UNC Lineberger Comprehensive Cancer Center researcher has identified genomic changes in head and neck cancers linked to the sexually transmitted disease HPV -- the latest finding of a collaborative scientific effort designed to map out the genomic changes driving cancer.
UNC geneticists create the first mouse model of ovarian clear cell carcinoma; show how a known drug can suppress tumor growth.
Research led by UNC Lineberger Comprehensive Cancer Center members Katherine Hoadley, PhD, research assistant professor in genetics and Chuck Perou, PhD, professor of genetics and pathology, was selected by the American Society of Clinical Oncology for inclusion in Clinical Cancer Advances 2015, the Society’s annual review of progress against cancer and emerging trends in the field. The study, a comprehensive tumor genetic analysis which revealed a new way of classifying cancers, is featured as one of the year’s major achievements in clinical cancer research and care.
Timothy R. Gershon, MD, PhD, and Vivian Gama, PhD, have been announced as the 2015 recipients of the Weatherspoon Family Brain Tumor Research Award.
After weighing the risk of serious side effects with the benefits of a breast cancer prevention drug, a study led by a University of North Carolina at Chapel Hill researcher found that the drug’s benefits outweighed risks for most, but not all women.
Eight year old Emily McCann of Apex came to the N.C. Cancer Hospital at the end of December bearing gifts. She brought money to help meet the needs of pediatric cancer patients, but she also brought cheer, comfort and hope.
Researchers look at area around tumors to help personalize treatment for triple-negative breast cancer
The Duke Endowment awards $461,750 grant to UNC Lineberger’s Comprehensive Cancer Support Program.
Ebix, Inc., today announced that the annual Ebix Charity Challenge, will be held in Greensboro, North Carolina on February 7, 2015. All proceeds from the 5th Annual Ebix Charity Challenge will benefit the UNC Lineberger Comprehensive Cancer Center, where America No. 1 John Isner’s mother, Karen, was successfully treated during her two battles with colon cancer.